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BACKGROUND
• Operative mortality for the Norwood procedure continues to improve for patients with HLHS or other complex SV lesions with systemic outflow tract obstruction. tract obstruction.
• As low as 10-20% in some centers.
• 
• Mortality of 20-70% in "high-risk" patients with intact/restrictive atrial septum, pre-op shock, renal failure, small ascending aorta, prematurity, low birthweight, ventricular dysfunction, significant AVVR, and/or extracardiac syndrome. and/or extracardiac syndrome.
• • Not only for first-stage palliation but also for those awaiting transplantation.
• Reduction in pulmonary blood flow by bPAB first reported for HLHS as an alternative to Norwood procedure in 1993.
• Gibbs et al, Br Heart J 1993
• Early success with hybrid palliation has led to its application for "high risk" HLHS and other SV lesions to optimize Qp:Qs imbalance and improve surgical outcomes.
PURPOSE
• To determine outcomes with bPAB and DS or PGE1 infusion in our "high-risk" neonates and infants with HLHS or other complex SV lesions as a means of resuscitation and stabilization to conventional of resuscitation and stabilization to conventional Norwood palliation or primary transplantation.
• To identify risk factors for hospital death. 
METHODS
• Echocardiographic, angiographic, operative and clinical data were reviewed.
• Hemodynamic, fluid balance and laboratory values were assessed immediately pre-bPAB and at 24 were assessed immediately pre-bPAB and at 24 hours and 4 days post-bPAB.
• End points included conventional Norwood, primary transplantation or hospital death. 
